+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 17Years - 65Years
All Genders
ID06915233

Evaluation of MACI Compared to Bone Marrow Stimulation for Treating Symptomatic Cartilage Defects of the Ankle in Adults Ages 17 to 65 A Prospective, Randomized, Multicenter Phase 3 Study to Assess Safety and Efficacy of MACI in Talus Lesions

Led by Vericel Corporation · Updated on 2026-10-26

309

Participants Needed

9

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of MACI autologous cultured chondrocytes on a porcine collagen membrane compared to Bone Marrow Stimulation for treating adults aged 17 to 65 years with symptomatic cartilage or bone-cartilage defects in the ankles talus region. This phase 3, open-label, multicenter trial aims to show that MACI is superior to the current surgical Bone Marrow Stimulation method for these ankle lesions. Participants will be randomly assigned in a 21 ratio to receive either a single MACI implantation or Bone Marrow Stimulation surgery. All will undergo an initial ankle arthroscopy to confirm eligibility and collect a cartilage biopsy. Those in the MACI group will have their biopsy processed to grow chondrocytes, followed by implantation via arthrotomy within 5 to 12 weeks after arthroscopy. Bone Marrow Stimulation participants will receive the procedure during the initial arthroscopy. Rehabilitation programs are recommended after treatment for all participants. Throughout the 2-year study, participants will attend follow-up visits at weeks 6, 12, 24, 36, 52, 78, and 104 to assess safety and treatment effectiveness. Researchers will monitor pain and ankle function using the FAOS Pain and Function subscale scores, along with other related assessments. Rehabilitation progress will be tracked through week 52. The study is sponsored by Vericel Corporation and aims to provide detailed long-term data about these cartilage repair treatments.

CONDITIONS

Brief Title

A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle

Research Team

V

Vericel Clinical Affairs

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here